23andMe cuts 40% of its workforce, discontinues all therapy programs CNNThe end of 23andMe’s drug discovery dream STAT23andMe to slash 40% of its workforce, end therapeutics program to cut costs MarketWatch23andMe to shut down its therapeutics division Endpoints News